Most Cited & Viewed

Most Cited & Viewed Papers

Citations Article
 
Prescribing Patterns of Antibiotics According to the WHO AWaRe Classification during the COVID-19 Pandemic at a Teaching Hospital in Lusaka, Zambia: Implications for Strengthening of Antimicrobial Stewardship Programmes
by Steward Mudenda, Eustus Nsofu, Patience Chisha, Victor Daka, Billy Chabalenge, Webrod Mufwambi, Henson Kainga, Manal H.G. Kanaan, Ruth L. Mfune, Florence Mwaba, Mildred Zulu, Rabecca Tembo, Wizaso Mwasinga, Kennedy Chishimba, Grace Mwikuma, Ngula Monde, Mulemba Samutela, Harriet K. Chiyangi, Shafiq Mohamed and Scott K. Matafwali
 
Use of Hand Sanitizers in COVID-19 Prevention: A Comprehensive Overview
by Suneetha Vuppu, Toshika Mishra and Arjun Chinamgari
 
Evaluation of the Effectiveness of Buprenorphine-Naloxone on Opioid Overdose and Death among Insured Patients with Opioid Use Disorder in the United States
by Tianyu Sun, Natallia Katenka, Stephen Kogut, Jeffrey Bratberg, Josiah Rich and Ashley Buchanan
 
COVID-19 and the COVID-19 Vaccine in Japan—A Review from a General Physician’s Perspective
by Hiroshi Kusunoki
 
Crises in Antimicrobial Stewardship: Misuse of Clarithromycin for Helicobacter pylori Therapy
by David Y. Graham
 
Identifying Surgical and Trauma Patients in New Zealand for Opioid-Related Pharmacoepidemiological Research: A Descriptive Study
by Jiayi Gong, Amy Hai Yan Chan, Kebede Beyene, Alan Forbes Merry, Andrew Tomlin and Peter Jones
 
Beyond Statins: Novel Lipid-Lowering Agents for Reducing Risk of Atherosclerotic Cardiovascular Disease
by Teimur Kayani, Bachar Ahmad, Rachel S. Chang, Frank Qian, Melis Sahinoz, Muhammad Waqar Rehan, Antonio Giaimo, Erica S. Spatz and Jiun-Ruey Hu
 
Adverse Drug Reactions in Multimorbid Older People Exposed to Polypharmacy: Epidemiology and Prevention
by Siobhán McGettigan, Denis Curtin and Denis O’Mahony
 
Cost Estimations of Managing Adverse Drug Reactions in Hospitalized Patients: A Systematic Review of Study Methods and Their Influences
by Siti Fauziah Abu, Asrul Akmal Shafie and Haarathi Chandriah
 
Remdesivir and the Liver: A Concise Narrative Review of Remdesivir-Associated Hepatotoxicity in Patients Hospitalized Due to COVID-19
by Alireza FakhriRavari and Mazyar Malakouti
Views Article
Prescribing Patterns of Antibiotics According to the WHO AWaRe Classification during the COVID-19 Pandemic at a Teaching Hospital in Lusaka, Zambia: Implications for Strengthening of Antimicrobial Stewardship Programmes
by Steward Mudenda, Eustus Nsofu, Patience Chisha, Victor Daka, Billy Chabalenge, Webrod Mufwambi, Henson Kainga, Manal H.G. Kanaan, Ruth L. Mfune, Florence Mwaba, Mildred Zulu, Rabecca Tembo, Wizaso Mwasinga, Kennedy Chishimba, Grace Mwikuma, Ngula Monde, Mulemba Samutela, Harriet K. Chiyangi, Shafiq Mohamed and Scott K. Matafwali
Antidepressants and the Risk of Fall-Related Injury in Older Adults with Incident Depression in the United States: A Comparative Safety Analysis
by Ashley Tabah, Laura S. Gold, Zachary A. Marcum and Ryan N. Hansen
Use of Hand Sanitizers in COVID-19 Prevention: A Comprehensive Overview
by Suneetha Vuppu, Toshika Mishra and Arjun Chinamgari
Beyond Statins: Novel Lipid-Lowering Agents for Reducing Risk of Atherosclerotic Cardiovascular Disease
by Teimur Kayani, Bachar Ahmad, Rachel S. Chang, Frank Qian, Melis Sahinoz, Muhammad Waqar Rehan, Antonio Giaimo, Erica S. Spatz and Jiun-Ruey Hu
Spironolactone Utilization among Patients with Reduced and Preserved Ejection Fraction Heart Failure
by Efe Eworuke, Austin Cosgrove, Qoua Liang Her, Jennifer G. Lyons, Dave Martin and Sruthi Adimadhyam
Cost Estimations of Managing Adverse Drug Reactions in Hospitalized Patients: A Systematic Review of Study Methods and Their Influences
by Siti Fauziah Abu, Asrul Akmal Shafie and Haarathi Chandriah
Adverse Drug Reactions in Multimorbid Older People Exposed to Polypharmacy: Epidemiology and Prevention
by Siobhán McGettigan, Denis Curtin and Denis O’Mahony
COVID-19 and the COVID-19 Vaccine in Japan—A Review from a General Physician’s Perspective
by Hiroshi Kusunoki
Helpful, Unnecessary, or Harmful: A Systematic Review of the Effects of Prescription Drug Monitoring Program Use on Opioid Prescriptions
by Nina Z. Y. Smith, J. Douglas Thornton, Susan H. Fenton, Debora Simmons and Tiffany Champagne-Langabeer
Evaluation of the Effectiveness of Buprenorphine-Naloxone on Opioid Overdose and Death among Insured Patients with Opioid Use Disorder in the United States
by Tianyu Sun, Natallia Katenka, Stephen Kogut, Jeffrey Bratberg, Josiah Rich and Ashley Buchanan
Downloads Article
Prescribing Patterns of Antibiotics According to the WHO AWaRe Classification during the COVID-19 Pandemic at a Teaching Hospital in Lusaka, Zambia: Implications for Strengthening of Antimicrobial Stewardship Programmes
by Steward Mudenda, Eustus Nsofu, Patience Chisha, Victor Daka, Billy Chabalenge, Webrod Mufwambi, Henson Kainga, Manal H.G. Kanaan, Ruth L. Mfune, Florence Mwaba, Mildred Zulu, Rabecca Tembo, Wizaso Mwasinga, Kennedy Chishimba, Grace Mwikuma, Ngula Monde, Mulemba Samutela, Harriet K. Chiyangi, Shafiq Mohamed and Scott K. Matafwali
Beyond Statins: Novel Lipid-Lowering Agents for Reducing Risk of Atherosclerotic Cardiovascular Disease
by Teimur Kayani, Bachar Ahmad, Rachel S. Chang, Frank Qian, Melis Sahinoz, Muhammad Waqar Rehan, Antonio Giaimo, Erica S. Spatz and Jiun-Ruey Hu
Identifying Surgical and Trauma Patients in New Zealand for Opioid-Related Pharmacoepidemiological Research: A Descriptive Study
by Jiayi Gong, Amy Hai Yan Chan, Kebede Beyene, Alan Forbes Merry, Andrew Tomlin and Peter Jones
Evaluation of the Effectiveness of Buprenorphine-Naloxone on Opioid Overdose and Death among Insured Patients with Opioid Use Disorder in the United States
by Tianyu Sun, Natallia Katenka, Stephen Kogut, Jeffrey Bratberg, Josiah Rich and Ashley Buchanan
Direct Oral Anticoagulants’ Consumption and Expenditure in the COVID-19 Pandemic in Russia and Clinical Practice Guidelines for Their Use
by Elena A. Baybulatova, Mikhail S. Chenkurov, Elina A. Korovyakova, Sergey K. Zyryanov and Liliya Eugenevna Ziganshina
Adverse Drug Reactions in Multimorbid Older People Exposed to Polypharmacy: Epidemiology and Prevention
by Siobhán McGettigan, Denis Curtin and Denis O’Mahony
Antidepressants and the Risk of Fall-Related Injury in Older Adults with Incident Depression in the United States: A Comparative Safety Analysis
by Ashley Tabah, Laura S. Gold, Zachary A. Marcum and Ryan N. Hansen
COVID-19 and the COVID-19 Vaccine in Japan—A Review from a General Physician’s Perspective
by Hiroshi Kusunoki
Cost Estimations of Managing Adverse Drug Reactions in Hospitalized Patients: A Systematic Review of Study Methods and Their Influences
by Siti Fauziah Abu, Asrul Akmal Shafie and Haarathi Chandriah
The Complexity in the Diagnosis and Treatment of Symptoms in Electronic Cigarette Users during the COVID-19 Pandemic
by Ayesha Rahman Ahmed and Mahiba Ahmed
Back to TopTop